OXGENE utilises an automated, high-throughput CRISPR engineering platform to meet the ever-increasing demand for custom cell line manufacture and generation of complex disease models.
Our optimised and quality assured CRISPR-Cas9 workflow means we can address large-scale gene editing projects that no-one else can deliver. Our mammalian cell engineering experts integrate bioinformatics and high-throughput technology to create a streamlined workflow for automated cell line engineering.
Beyond this, we’re expanding our capabilities to disease relevant cell lines, stem cell models, and complex genomic modifications.
Download this resource to read on...